A Single Center, Non-randomized, Single Blind, Placebo Controlled, Single Dose Study of the Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients - Phase 1 Study.
Phase of Trial: Phase I
Latest Information Update: 16 Apr 2012
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 22 Feb 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.